4//SEC Filing
Viveash Dawn 4
Accession 0001181431-11-036552
CIK 0001382911other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 4:46 PM ET
Size
5.7 KB
Accession
0001181431-11-036552
Insider Transaction Report
Form 4
Viveash Dawn
Head of Regulatory Affairs
Transactions
- Award
Stock Option (right to buy)
2011-06-10+72,000→ 72,000 totalExercise: $1.69Exp: 2021-06-09→ Common Stock (72,000 underlying)
Footnotes (2)
- [F1]1/48th of the total number of shares of stock subject to the option (rounded down to the next whole number of shares) shall vest on the same day of each one-month period of the reporting persons service as an employee, director or consultant following June 10, 2011, so that all of the shares of the stock subject to the option shall be vested on June 10, 2015, subject to the reporting persons continued service relationship (whether as an employee, director or consultant) with the Company or any parent or subsidiary on each such date.
- [F2]Not applicable.
Documents
Issuer
Orexigen Therapeutics, Inc.
CIK 0001382911
Entity typeother
Related Parties
1- filerCIK 0001475720
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 4:46 PM ET
- Size
- 5.7 KB